Transcatheter arterial chemoembolization for gastrointestinal stromal tumors with liver metastases.

Item

http://www.wikidata.org/entity/Q36395393

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Transcatheter arterial chemoem ...... tumors with liver metastases.

@ast

Transcatheter arterial chemoem ...... tumors with liver metastases.

@en

type

Item

label

Transcatheter arterial chemoem ...... tumors with liver metastases.

@ast

Transcatheter arterial chemoem ...... tumors with liver metastases.

@en

prefLabel

Transcatheter arterial chemoem ...... tumors with liver metastases.

@ast

Transcatheter arterial chemoem ...... tumors with liver metastases.

@en

P1476

Transcatheter arterial chemoem ...... tumors with liver metastases.

@en

P2093

Guang Cao

http://www.w3.org/2001/XMLSchema#string

Jian Li

http://www.w3.org/2001/XMLSchema#string

Lin Shen

http://www.w3.org/2001/XMLSchema#string

Xu Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

Contrast of response to dacarbazine, mitomycin, doxorubicin, and cisplatin (DMAP) plus GM-CSF between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas.

A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas.

Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature.

Molecular basis and management of gastrointestinal stromal tumors

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial.

Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors.

Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.

P304

6134-6140

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V18.I42.6134

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233424394

http://www.w3.org/2001/XMLSchema#string

P698

23155343

http://www.w3.org/2001/XMLSchema#string

P932

3496891

http://www.w3.org/2001/XMLSchema#string